-
S648956-5mgSPDB-DM4 is a agent-linker conjugate for ADC by using the maytansinebased payload (DM4, a tubulin inhibitor) via a SPDB linker, exhibiting potent anti-tumor activity.Form:SolidIC50&: Target:Maytansinoids.
-
S647477-10mgSPP-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker SPPForm:SolidIC50&: Target:Maytansinoids.
-
S647477-25mgSPP-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker SPPForm:SolidIC50&: Target:Maytansinoids.
-
S647477-50mgSPP-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker SPPForm:SolidIC50&: Target:Maytansinoids.
-
S164299-250mgStearic acid is an 18 carbon saturated fatty acid lipid with excellent hydrophobicity. PEG modified stearic acid is an excellent amphilphilic polymer with both hydrophilicity and hydrophobility. Pegylated lipids are excellent liposome formation
-
S164299-50mgStearic acid is an 18 carbon saturated fatty acid lipid with excellent hydrophobicity. PEG modified stearic acid is an excellent amphilphilic polymer with both hydrophilicity and hydrophobility. Pegylated lipids are excellent liposome formation
-
S164300-250mgStearic acid PEG aldehyde.
-
S164300-50mgStearic acid PEG aldehyde.
-
S164301-250mgStearic acid PEG aldehyde.
-
S164301-50mgStearic acid PEG aldehyde.
-
S164302-250mgStearic acid PEG aldehyde.
-
S164302-50mgStearic acid PEG aldehyde.